BioInvent International AB (publ) announced appointed The members of the Nomination Committee for company's Annual General Meeting in 2023 have now been appointed. The following representatives of BioInvent International AB's shareholders will be members of the Nomination Committee for the Annual General Meeting 2023: Laura Feinleib, appointed by Redmile Group, LLC, Erik Esveld, appointed by van Herk Investments B.V., Dr. Ivo Staijen appointed by HBM Healthcare Investments Ltd, and Leonard Kruimer, Chairman of the Board. The Nomination Committee shall prepare proposals for the Annual General Meeting in 2023 regarding Chairman of the General Meeting, Chairman of the Board and other Board members, board remuneration shared among the Chairman and other Board members and possible compensation for committee work.